Hauser B - Search Results

1

When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis.

Hayes KN, Baschant U, Hauser B, Burden AM, Winter EM. Hayes KN, et al. Among authors: hauser b. Front Endocrinol (Lausanne). 2021 Dec 15;12:782118. doi: 10.3389/fendo.2021.782118. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34975756 Free PMC article. Review.

2

The Impact of High Dose Glucocorticoids on Bone Health and Fracture Risk in Systemic Vasculitides.

Box CD, Cronin O, Hauser B. Box CD, et al. Among authors: hauser b. Front Endocrinol (Lausanne). 2022 Feb 16;13:806361. doi: 10.3389/fendo.2022.806361. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35250864 Free PMC article. Review.

3

Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis.

Hayes KN, Baschant U, Hauser B, Burden AM, Winter EM. Hayes KN, et al. Among authors: hauser b. Front Endocrinol (Lausanne). 2022 Mar 14;13:877512. doi: 10.3389/fendo.2022.877512. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35370960 Free PMC article.

4

Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study.

Hayes KN, Burden AM, Winter EM, Hauser B. Hayes KN, et al. Among authors: hauser b. Rheumatol Adv Pract. 2022 Feb 17;6(2):rkac010. doi: 10.1093/rap/rkac010. eCollection 2022. Rheumatol Adv Pract. 2022. PMID: 35531047 Free PMC article. No abstract available.

5

Editorial: Glucocorticoid and bone: Friend or foe.

Baschant U, Hauser B, Winter EM. Baschant U, et al. Among authors: hauser b. Front Endocrinol (Lausanne). 2022 Aug 11;13:995124. doi: 10.3389/fendo.2022.995124. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36034450 Free PMC article. No abstract available.

6

Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis.

Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH. Hauser B, et al. Rheumatology (Oxford). 2014 Oct;53(10):1759-66. doi: 10.1093/rheumatology/keu162. Epub 2014 Apr 24. Rheumatology (Oxford). 2014. PMID: 24764264

7

Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups.

Hauser B, Alonso N, Riches PL. Hauser B, et al. J Clin Med. 2021 Apr 1;10(7):1403. doi: 10.3390/jcm10071403. J Clin Med. 2021. PMID: 33915736 Free PMC article. Review.

8

Communicating Absolute Fracture Risk Reduction and the Acceptance of Treatment for Osteoporosis.

Ralston KAP, Phillips J, Krause A, Hauser B, Ralston SH. Ralston KAP, et al. Among authors: hauser b. Calcif Tissue Int. 2022 Jun;110(6):698-702. doi: 10.1007/s00223-022-00948-2. Epub 2022 Feb 13. Calcif Tissue Int. 2022. PMID: 35152304 Free PMC article.

9

The Effect of Anti-rheumatic Drugs on the Skeleton.

Hauser B, Raterman H, Ralston SH, Lems WF. Hauser B, et al. Calcif Tissue Int. 2022 Nov;111(5):445-456. doi: 10.1007/s00223-022-01001-y. Epub 2022 Jun 30. Calcif Tissue Int. 2022. PMID: 35771255 Free PMC article. Review.

10

Effective Communication and the Osteoporosis Care Gap.

Ralston KAP, Hauser B, Paskins Z, Ralston SH. Ralston KAP, et al. Among authors: hauser b. J Bone Miner Res. 2022 Nov;37(11):2049-2054. doi: 10.1002/jbmr.4701. Epub 2022 Oct 2. J Bone Miner Res. 2022. PMID: 36183670 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

426 results

Search Page